Metropolitan Life Insurance Company (MetLife)’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,467
Closed -$738K 956
2024
Q1
$738K Sell
9,467
-503
-5% -$37.4K 0.03% 393
2023
Q4
$712K Sell
9,970
-163
-2% -$11.3K 0.03% 394
2023
Q3
$703K Sell
10,133
-592
-6% -$44.7K 0.04% 366
2023
Q2
$868K Sell
10,725
-302
-3% -$24.7K 0.04% 349
2023
Q1
$890K Sell
11,027
-2,825
-20% -$227K 0.05% 342
2022
Q4
$1.04M Sell
13,852
-619
-4% -$44.1K 0.05% 360
2022
Q3
$934K Sell
14,471
-159
-1% -$11K 0.04% 367
2022
Q2
$1.01M Sell
14,630
-408
-3% -$30.3K 0.04% 365
2022
Q1
$1.16M Sell
15,038
-13,490
-47% -$970K 0.04% 373
2021
Q4
$2.18M Sell
28,528
-833
-3% -$61.2K 0.03% 477
2021
Q3
$2.17M Sell
29,361
-1,339
-4% -$100K 0.03% 465
2021
Q2
$2.05M Sell
30,700
-10,023
-25% -$670K 0.03% 517
2021
Q1
$3.03M Sell
40,723
-2,216
-5% -$168K 0.05% 348
2020
Q4
$3.13M Sell
42,939
-2,200
-5% -$155K 0.05% 325
2020
Q3
$3M Sell
45,139
-1,774
-4% -$112K 0.05% 298
2020
Q2
$2.67M Sell
46,913
-2,730
-5% -$134K 0.05% 321
2020
Q1
$1.74M Sell
49,643
-916
-2% -$43.6K 0.04% 439
2019
Q4
$2.64M Sell
50,559
-97
-0.2% -$4.83K 0.04% 399
2019
Q3
$2.56M Buy
50,656
+10,640
+27% +$524K 0.04% 382
2019
Q2
$1.92M Buy
40,016
+2,911
+8% +$135K 0.03% 542
2019
Q1
$1.8M Sell
37,105
-1,669
-4% -$75.3K 0.03% 546
2018
Q4
$1.59M Sell
38,774
-111
-0.3% -$4.55K 0.03% 554
2018
Q3
$1.59M Sell
38,885
-1,598
-4% -$64.6K 0.03% 649
2018
Q2
$1.61M Sell
40,483
-8,947
-18% -$344K 0.03% 646
2018
Q1
$1.85M Buy
49,430
+165
+0.3% +$6.67K 0.03% 578
2017
Q4
$2.11M Sell
49,265
-90,529
-65% -$3.61M 0.03% 513
2017
Q3
$5.13M Sell
139,794
-2,041
-1% -$82.4K 0.03% 574
2017
Q2
$6.44M Sell
141,835
-7,475
-5% -$330K 0.04% 422
2017
Q1
$6.35M Sell
149,310
-1,581
-1% -$64.5K 0.04% 442
2016
Q4
$6.05M Sell
150,891
-3,188
-2% -$123K 0.04% 446
2016
Q3
$5.98M Buy
154,079
+15,034
+11% +$568K 0.04% 436
2016
Q2
$4.81M Sell
139,045
-922
-0.7% -$31.9K 0.04% 537
2016
Q1
$4.83M Sell
139,967
-88,048
-39% -$3.07M 0.04% 534
2015
Q4
$8.82M Buy
228,015
+2,197
+1% +$85.5K 0.07% 277
2015
Q3
$8.84M Sell
225,818
-1,261
-0.6% -$50K 0.06% 282
2015
Q2
$8.64M Buy
227,079
+9,329
+4% +$327K 0.06% 306
2015
Q1
$7.19M Buy
217,750
+8,357
+4% +$256K 0.05% 364
2014
Q4
$5.6M Buy
209,393
+2,579
+1% +$66.6K 0.04% 482
2014
Q3
$5.03M Sell
206,814
-26,552
-11% -$670K 0.04% 503
2014
Q2
$5.92M Buy
233,366
+1,227
+0.5% +$28.7K 0.04% 458
2014
Q1
$4.99M Buy
232,139
+5,345
+2% +$115K 0.03% 534
2013
Q4
$5.07M Buy
226,794
+3,022
+1% +$66.6K 0.04% 507
2013
Q3
$4.62M Buy
223,772
+3,716
+2% +$79.1K 0.04% 520
2013
Q2
$4.25M Buy
+220,056
New +$4.6M 0.03% 512

Other funds holding HOLX

Metropolitan Life Insurance Company (MetLife)'s HOLX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Hologic (HOLX) in Q2 2024, closing a stake of 9,467 shares — an estimated $738K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in HOLX in Q2 2013 and held it in 44 quarters. The position peaked at $8.84M in Q3 2015. 703 funds tracked by Wall St. Rank hold HOLX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Hologic position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 9,467 Hologic shares in Q2 2024, an estimated $738K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Hologic in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Hologic position peaked at $8.84M in Q3 2015.
  • 703 funds tracked by Wall St. Rank held Hologic as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.